DARPA is offering this grant through its Dialysis Like Therapeutics (DLT) program to solicit innovative research proposals aimed at managing life-threatening sepsis. This grant is for the purpose of developing a portable device capable of controlling relevant components within the entire blood volume on clinically relevant time scales. Achieving this goal necessitates significant advancements in sensing, complex fluid manipulation, separation of components from fluids, and mathematical descriptions for predictive control over the closed-loop process. The envisioned device is critical for saving thousands of military patients annually by effectively treating sepsis and its associated complications, providing a vital therapeutic solution.
Opportunity ID: 69513
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | DARPA-BAA-11-30 |
Funding Opportunity Title: | Dialysis Like Therapeutics (DLT) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant Other Procurement Contract |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 12.910 — Research and Technology Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Feb 08, 2011 |
Last Updated Date: | – |
Original Closing Date for Applications: | Apr 01, 2011 Important Dates: Posting Date: February 8, 2011 Proposer’s Day Date: February 23, 2011 in Arlington, VA Full Proposal Due Date: April 1, 2011 |
Current Closing Date for Applications: | Apr 01, 2011 Important Dates: Posting Date: February 8, 2011 Proposer’s Day Date: February 23, 2011 in Arlington, VA Full Proposal Due Date: April 1, 2011 |
Archive Date: | Oct 03, 2011 |
Estimated Total Program Funding: | – |
Award Ceiling: | $0 |
Award Floor: | $0 |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | DARPA – Microsystems Technology Office |
Description: | DARPA is soliciting innovative research proposals to manage the life-threatening blood infection known as sepsis. The goal of the Dialysis Like Therapeutics (DLT) program is to develop a portable device capable of controlling relevant components in the entire blood volume on clinically relevant time scales. Reaching this goal is expected to require significant advances in sensing, complex fluid manipulation, separation of components from these fluids, and mathematical descriptions capable of providing predictive control over the closed-loop process. The envisioned device would save the lives of thousands of military patients each year by effectively treating sepsis and associated complications. See full DARPA-BAA-11-30 attached. |
Link to Additional Information: | MTO Solicitations page |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Dr. Timothy Broderick
DARPA PM Email:DARPA-BAA-11-30@darpa.mil |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 69513 Full Announcement-1 -> approved proposer checklist.pdf
Folder 69513 Full Announcement-1 -> darpa-baa-11-30_dlt_final for posting_8feb11.pdf
Packages
Agency Contact Information: | Dr. Timothy Broderick DARPA PM Email: DARPA-BAA-11-30@darpa.mil |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.910 | PKG00031850 | Feb 08, 2011 | Apr 01, 2011 | View |
Package 1
Mandatory forms
69513 RR_SF424-1.1.pdf
Optional forms
69513 RR_FedNonFedBudget-1.1.pdf
69513 RR_FedNonFed_SubawardBudget-1.2.pdf
69513 RR_OtherProjectInfo-1.1.pdf
69513 RR_Budget-1.1.pdf
69513 RR_KeyPersonExpanded-1.1.pdf
69513 RR_PerformanceSite-1.1.pdf
69513 RR_SubawardBudget-1.2.pdf